BPAP was first described in 1999. There has been interest in BPAP for potential clinical use in humans, including in the treatment of Parkinson's disease, Alzheimer's disease, and depression. There has also been interest in BPAP to help slow aging.
Benzofuranylpropylaminopentane: BPAP was... - Cure Parkinson's
Benzofuranylpropylaminopentane
Written by
Farooqji
To view profiles and participate in discussions please or .
Read more about...
Not what you're looking for?
You may also like...
Question about Thiamine
I've read with great interest the many posts about using Thiamine as a PD treatment. I'm new to...
Much has been said about the unproven coconut oil claims but little about the well documented and more promising curcumin
For over a year now, I've gotten daily "Google Alerts" on both coconut oil and curcumin. Most of...
Nilotinib Does Not Show Promise for Benefit in Phase II Nilotinib for Parkinson’s Disease (NILO-PD) Trial
Nilotinib seen to be safe and tolerable, but study strictly excluded those with heart issues or...
T shirt slogans for PWPD
In the interest of being "out there" and also maintaining a sense of humor, I'm trying to think of...
Mechanisms of motor symptom improvement by long-term Tai Chi training in Parkinson’s disease patients 2022
I know what I will learning tomorrow. Tai Chi!
Mechanisms of motor symptom improvement by long-term...
Newbie Question re: Mucuna Pruriens
Mechanism by which Alpha synuclein causes neuronal cell death found
The Friendly Prune: more than just a laxative
I am now a B1 Believer :-) +* 6/21/22 day 36 of taking TTDF: 
Method generates dopaminergic neurons lost in Parkinson’s disease
